Extended interval between first and second dose of Pfizer-BioNTech vaccine enhances antibody response in older people

Researchers from the University of Birmingham recruited a cohort of older adults to compare the immune response from the standard dosing schedule to that of an extended interval dosing schedule for the Pfizer-BioNTech vaccine.